AssetMark Inc
SPTX

AssetMark Inc’s Seaport Therapeutics SPTX Stock Holding History

AssetMark Inc’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1K Buy
+1,431
New +$25.2K ﹤0.01% 2022

Other funds holding SPTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AssetMark Inc's SPTX Position: Q2 2026 in Review

AssetMark Inc opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 1,431 shares worth $31.1K. The stake represents ﹤0.01% of the portfolio and ranks #2022 among its holdings.

5 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

  • AssetMark Inc held 1,431 shares of Seaport Therapeutics worth $31.1K as of Q2 2026.
  • Seaport Therapeutics was a new AssetMark Inc position in Q2 2026.
  • Seaport Therapeutics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2022 holding.
  • 5 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.